Activation of PPARδ counteracts angiotensin II-induced ROS generation by inhibiting rac1 translocation in vascular smooth muscle cells

References

• Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494–501.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97: 1916–1923.
   PubMed Web of Science ®Google Scholar
• Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74: 1141–1148.
   PubMed Web of Science ®Google Scholar
• Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52:639–672.
   Google Scholar
• Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82–C97.
   PubMed Web of Science ®Google Scholar
• Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005;65:16–27.
   PubMed Web of Science ®Google Scholar
• Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006;21:269–280.
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996;271:23317–23321.
   PubMed Web of Science ®Google Scholar
• Frank GD, Eguchi S, Inagami T, Motley ED. N-acetylcysteine inhibits angiotensin II-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor. Biochem Biophys Res Commun 2001;280:1116–1119.
   PubMedGoogle Scholar
• Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998;83:952–959.
   PubMed Web of Science ®Google Scholar
• Dikalova A, Clempus R, Lassègue B, Cheng G, McCoy J, Dikalov S, . Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 2005;112:2668–2676.
   PubMed Web of Science ®Google Scholar
• Weber DS, Rocic P, Mellis AM, Laude K, Lyle AN, Harrison DG, Griendling KK. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2005;288:H37–H42.
   Google Scholar
• Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 2006;580:497–504.
   PubMed Web of Science ®Google Scholar
• Graham TL, Mookherjee C, Suckling KE, Palmer CN, Patel L. The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice. Atherosclerosis 2005;181:29–37.
   PubMed Web of Science ®Google Scholar
• Jandeleit-Dahm KA, Calkin A, Tikellis C, Thomas M. Direct antiatherosclerotic effects of PPAR agonists. Curr Opin Lipidol 2009;20:24–29.
   Google Scholar
• Ehrenborg E, Krook A. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol Rev 2009;61:373–393.
   PubMed Web of Science ®Google Scholar
• Lee CH, Chawla A, Urbiztondo N, Liao D, Boisvert WA, Evans RM, Curtiss LK. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 2003;302: 453–457.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Ham SA, Kim SU, Hwang JY, Kim JH, Chang KC, . Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta. Circ Res 2008;102:193–200.
   Google Scholar
• Kim HJ, Kim MY, Jin H, Kim HJ, Kang SS, Kim HJ, . Peroxisome proliferator-activated receptor {delta} regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-{beta}1/Smad3. Circ Res 2009;105:16–24.
   Google Scholar
• Kim HJ, Kim MY, Hwang JS, Kim HJ, Lee JH, Chang KC, . PPARdelta inhibits IL-1beta-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra. Cell Mol Life Sci 2010;67:2119–2130.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Ham SA, Paek KS, Hwang JS, Jung SY, Kim MY, . Transcriptional up-regulation of antioxidant genes by PPARδ inhibits angiotensin II-induced premature senescence in vascular smooth muscle cells. Biochem Biophys Res Commun 2011;406:564–569.
   Google Scholar
• Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003;113:159–170.
   PubMed Web of Science ®Google Scholar
• Diep QN, Amiri F, Touyz RM, Cohn JS, Endemann D, Neves MF, Schiffrin EL. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 2002; 40:866–871.
   PubMed Web of Science ®Google Scholar
• Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christopher TA, . Antioxidative, antinitartive, and vasculoprotective effects of a peroxisome proliferator-activated receptor agonist in hypercholesterolemia. Circulation 2003;108:2805–2811.
   PubMed Web of Science ®Google Scholar
• Cantley IC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655–1657.
   PubMed Web of Science ®Google Scholar
• Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, . Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001;88: 888–894.
   PubMed Web of Science ®Google Scholar
• Ehrenborg E, Krook A. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor δ. Pharmacol Rev 2009;61:373–393.
   PubMed Web of Science ®Google Scholar
• Han JK, Lee HS, Yang HM, Hur J, Jun SI, Kim JY, . Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Circulation 2008;118:1021–1033.
   Google Scholar
• Sawada N, Li Y, Liao JK. Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. Curr Opin Pharmacol 2010;10:116–121.
   Google Scholar
• Zhang C, Yang J, Jacobs JD, Jennings LK. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. Am J Physiol Heart Circ Physiol 2003;285: H2563–H2572.
   PubMed Web of Science ®Google Scholar
• Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87:840–844.
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, . Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med 2012;52:1–6.
   PubMed Web of Science ®Google Scholar
• Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002;91: 406–413.
   PubMed Web of Science ®Google Scholar
• Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, Alexander RW. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 2005;25:1824–1830.
   PubMed Web of Science ®Google Scholar
• Barth BM, Stewart-Smeets S, Kuhn TB. Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase. Mol Cell Neurosci 2009;41:274–285.
   PubMed Web of Science ®Google Scholar
• Diebold I, Djordjevic T, Petry A, Hatzelmann A, Tenor H, Hess J, Görlach A. Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. Circ Res 2009;104: 1169–1177.
   PubMed Web of Science ®Google Scholar